Non-fatal Overdose Prevalence and Associated Factors among People Who Inject Drugs in Iran

IF 3.2 3区 医学 Q2 PSYCHIATRY
Fatemeh Tavakoli, Frishta Nafeh, Sanam Hariri, Shahryar Moradi Falah Langeroodi, Mehrdad Khezri, Soheil Mehmandoost, Ali Mirzazadeh, Mostafa Shokoohi, Hamid Sharifi, Mohammad Karamouzian
{"title":"Non-fatal Overdose Prevalence and Associated Factors among People Who Inject Drugs in Iran","authors":"Fatemeh Tavakoli, Frishta Nafeh, Sanam Hariri, Shahryar Moradi Falah Langeroodi, Mehrdad Khezri, Soheil Mehmandoost, Ali Mirzazadeh, Mostafa Shokoohi, Hamid Sharifi, Mohammad Karamouzian","doi":"10.1007/s11469-024-01364-3","DOIUrl":null,"url":null,"abstract":"<p>We characterized overdose prevalence and its correlates among people who inject drugs (PWID) in Iran. Our analysis included 2618 PWID with a recent history of drug injection, recruited from 11 cities across Iran using a respondent-driven sampling approach. The primary outcome was a lifetime history of drug-related non-fatal overdose. The nation-wide lifetime prevalence of overdose among PWID was 21.7%, with considerable variations across different cities. In the multivariable analysis, older age, being men, history of homelessness, younger age at injection initiation, recent stimulant injection, recent non-prescribed benzodiazepine use, lifetime suicide attempt, and HIV sero-positivity were positively associated with a history of non-fatal overdose. Our findings underscore the need for comprehensive and tailored approaches to overdose prevention and treatment in Iran, including increased access to take-home naloxone for PWID. The diverse risk profiles of PWID should also be considered in the development of substance use harm reduction policies in Iran, reflecting their varied needs in terms of mental, physical, and social well-being.</p>","PeriodicalId":14083,"journal":{"name":"International Journal of Mental Health and Addiction","volume":"66 1","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2024-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Mental Health and Addiction","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11469-024-01364-3","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

We characterized overdose prevalence and its correlates among people who inject drugs (PWID) in Iran. Our analysis included 2618 PWID with a recent history of drug injection, recruited from 11 cities across Iran using a respondent-driven sampling approach. The primary outcome was a lifetime history of drug-related non-fatal overdose. The nation-wide lifetime prevalence of overdose among PWID was 21.7%, with considerable variations across different cities. In the multivariable analysis, older age, being men, history of homelessness, younger age at injection initiation, recent stimulant injection, recent non-prescribed benzodiazepine use, lifetime suicide attempt, and HIV sero-positivity were positively associated with a history of non-fatal overdose. Our findings underscore the need for comprehensive and tailored approaches to overdose prevention and treatment in Iran, including increased access to take-home naloxone for PWID. The diverse risk profiles of PWID should also be considered in the development of substance use harm reduction policies in Iran, reflecting their varied needs in terms of mental, physical, and social well-being.

Abstract Image

伊朗注射吸毒者中的非致命过量流行率和相关因素
我们描述了伊朗注射吸毒者(PWID)中吸毒过量流行率及其相关因素。我们的分析对象包括 2618 名近期有毒品注射史的注射吸毒者,他们是通过受访者驱动的抽样方法从伊朗 11 个城市招募的。主要结果是终生有过与毒品相关的非致命性用药过量史。全国范围内吸毒过量的流行率为 21.7%,不同城市之间差异很大。在多变量分析中,年龄较大、男性、无家可归史、开始注射的年龄较小、近期注射兴奋剂、近期使用非处方苯并二氮杂卓、终生自杀未遂以及艾滋病毒血清阳性与非致命性用药过量史呈正相关。我们的研究结果表明,伊朗需要采取全面和有针对性的方法来预防和治疗用药过量,包括让更多的吸毒者获得可带回家的纳洛酮。在伊朗制定减少药物使用危害的政策时,还应考虑到吸毒者的不同风险特征,以反映他们在精神、身体和社会福祉方面的不同需求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
15.90
自引率
2.50%
发文量
245
审稿时长
6-12 weeks
期刊介绍: The International Journal of Mental Health and Addictions (IJMH) is a publication that specializes in presenting the latest research, policies, causes, literature reviews, prevention, and treatment of mental health and addiction-related topics. It focuses on mental health, substance addictions, behavioral addictions, as well as concurrent mental health and addictive disorders. By publishing peer-reviewed articles of high quality, the journal aims to spark an international discussion on issues related to mental health and addiction and to offer valuable insights into how these conditions impact individuals, families, and societies. The journal covers a wide range of fields, including psychology, sociology, anthropology, criminology, public health, psychiatry, history, and law. It publishes various types of articles, including feature articles, review articles, clinical notes, research notes, letters to the editor, and commentaries. The journal is published six times a year.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信